Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telaprevir”

88 trials

Showing 20 of 88 results

Large-scale testing (Phase 3)Ended earlyNCT01821963
What this trial is testing

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Who this might be right for
Infection
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT02004379
What this trial is testing

Register of Telaprevir and Boceprevir in Routine Clinical Practice

Who this might be right for
Hepatitis C
Fundación Pública Andaluza Progreso y Salud 1,553
Early research (Phase 1)Study completedNCT01818856
What this trial is testing

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Who this might be right for
Hepatitis C, ChronicHIV Infection
Hospitales Universitarios Virgen del Rocío 14
Early research (Phase 1)Study completedNCT00775125
What this trial is testing

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Who this might be right for
Hepatitis CTelaprevirHIV
Tibotec BVBA 40
Large-scale testing (Phase 3)Study completedNCT01492426
What this trial is testing

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 605
Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Testing effectiveness (Phase 2)Study completedNCT01994486
What this trial is testing

Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
University of Florida 20
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Early research (Phase 1)Study completedNCT00933283
What this trial is testing

Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State

Who this might be right for
Healthy Participants
Tibotec BVBA 18
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Not applicableStudy completedNCT02113631
What this trial is testing

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir

Who this might be right for
Hepatitis C, ChronicCirrhosis
Louis Stokes VA Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Post-approval studies (Phase 4)Study completedNCT01743521
What this trial is testing

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 14
Early research (Phase 1)Study completedNCT01038167
What this trial is testing

Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 20
Post-approval studies (Phase 4)WithdrawnNCT01415141
What this trial is testing

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Who this might be right for
Hepatitis C
University of Vermont
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Large-scale testing (Phase 3)Study completedNCT01571583
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
Janssen-Cilag International NV 74
Early research (Phase 1)Study completedNCT01563328
What this trial is testing

Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation